ATE470674T1 - Abgeschwächte gramnegative bakterien - Google Patents

Abgeschwächte gramnegative bakterien

Info

Publication number
ATE470674T1
ATE470674T1 AT07018562T AT07018562T ATE470674T1 AT E470674 T1 ATE470674 T1 AT E470674T1 AT 07018562 T AT07018562 T AT 07018562T AT 07018562 T AT07018562 T AT 07018562T AT E470674 T1 ATE470674 T1 AT E470674T1
Authority
AT
Austria
Prior art keywords
gram
weakened
bacterium
negative bacteria
mutant
Prior art date
Application number
AT07018562T
Other languages
English (en)
Inventor
Helen Rachel Crooke
Jacqueline Elizabeth Shea
Robert Graham Feldman
Sylvain Gabriel Goutebroze
Gros Francois-Xavier Le
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE470674T1 publication Critical patent/ATE470674T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT07018562T 2002-04-05 2002-04-05 Abgeschwächte gramnegative bakterien ATE470674T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02290861A EP1350796B1 (de) 2002-04-05 2002-04-05 Attenuirte Gram-negative Bakterien

Publications (1)

Publication Number Publication Date
ATE470674T1 true ATE470674T1 (de) 2010-06-15

Family

ID=27838168

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02290861T ATE420105T1 (de) 2002-04-05 2002-04-05 Attenuirte gram-negative bakterien
AT07018562T ATE470674T1 (de) 2002-04-05 2002-04-05 Abgeschwächte gramnegative bakterien

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02290861T ATE420105T1 (de) 2002-04-05 2002-04-05 Attenuirte gram-negative bakterien

Country Status (7)

Country Link
EP (2) EP1350796B1 (de)
AT (2) ATE420105T1 (de)
CY (1) CY1108972T1 (de)
DE (2) DE60236698D1 (de)
DK (1) DK1350796T3 (de)
ES (2) ES2320419T3 (de)
PT (2) PT1914239E (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449178B2 (en) 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
NZ543771A (en) * 2003-07-02 2008-05-30 Biotechnology Res & Dev Acapsular Pasteurella multocida hyae deletion mutants
AU2005331860B2 (en) * 2004-12-22 2011-08-11 Intervet International B.V. Pasteurella multocida vaccine
TWI328458B (en) * 2007-03-09 2010-08-11 Univ Nat Chunghsing Subunit vaccine of pasteurella multocida in veterinary uses
WO2008118902A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
CN102304493B (zh) * 2011-09-14 2012-09-12 扬州大学 一株针对鸭疫里默氏杆菌的单抗

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
DE69233158T2 (de) 1991-03-07 2004-05-13 Connaught Technology Corp., Greenville Gentechnologisch hergestellter stamm für impfstoffe
CA2148829A1 (en) * 1992-11-06 1994-05-26 Keum Hwa Choi Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis
DE69526377T2 (de) * 1994-12-09 2002-11-07 Microscience Ltd Virulenzgene in der VGC2-Region von Salmonella
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
TWI224107B (en) 1998-10-22 2004-11-21 Pfizer Prod Inc Novel proteins from actinobacillus pleuropneumoniae
EP1171577A2 (de) * 1999-04-09 2002-01-16 PHARMACIA & UPJOHN COMPANY Antibakterielle vakzinzusammensetzungen
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria

Also Published As

Publication number Publication date
DK1350796T3 (da) 2009-03-02
EP1350796A1 (de) 2003-10-08
ES2346915T3 (es) 2010-10-21
EP1914239B1 (de) 2010-06-09
ES2320419T3 (es) 2009-05-22
CY1108972T1 (el) 2014-07-02
PT1350796E (pt) 2009-01-23
DE60236698D1 (de) 2010-07-22
EP1350796B1 (de) 2009-01-07
ATE420105T1 (de) 2009-01-15
DE60230717D1 (de) 2009-02-26
PT1914239E (pt) 2010-07-30
EP1914239A1 (de) 2008-04-23

Similar Documents

Publication Publication Date Title
ATE518955T1 (de) Abgeschwächte gram-negative bakterien
IL142231A0 (en) Mutant cholera holotoxin as an adjuvant
MX9705727A (es) Variantes de amilasa.
BR9906927A (pt) Proteìnas de neisseria meningitidis
DK0721506T3 (da) Bakterielle eksporterede proteiner og acellulære vacciner baseret derpå
ATE382685T1 (de) Bakteriophagen-lysin
ES2535961T3 (es) Bacteria pasteurelácea atenuada que tiene una mutación en un gen de virulencia
ATE470674T1 (de) Abgeschwächte gramnegative bakterien
DE69836520D1 (de) Clostridium perfringens Impfstoff
BR9506038A (pt) Dna clonato vetor recombinante e planta
KR930013104A (ko) 세르풀리나 하이오다이센테리애 백신
HUP0104552A2 (hu) Orális vakcina hasmenés ellen
WO2003022039A1 (fr) Procede permettant de conferer une resistance a un virus au moyen d'une proteine vegetale se liant a une proteine de transport de virus vegetal
NO20025126L (no) (R)-2-hydroksy-3-fenylpropionisk syre (D-fenylmelkesyre) dehydrogenase, oggen som koder for samme
GB9027901D0 (en) Acellular vaccine
YU29801A (sh) Gen prv-1 i njegova primena
EP1158052A4 (de) Beta-primeverosidase gen
CA2262500A1 (en) Measles virus mutant antigen and gene coding for the same
ATE409747T1 (de) Mit wt1 interagierendes protein, wtip
DK0663955T3 (da) Nucleinsyre, som koder for en alfa-acetolactat-decarboxylase, og anvendelser deraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1914239

Country of ref document: EP